Nicolet Bankshares’s Novartis NVS Stock Holding History

Nicolet Bankshares’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Hold	1,500	–	–	0.01%	562
2026 Q1	$229K	Buy	+1,500	New	+$230K	0.01%	519

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nicolet Bankshares's NVS Position: Q2 2026 in Review

Nicolet Bankshares held its Novartis (NVS) position steady in Q2 2026 at 1,500 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #562.

Nicolet Bankshares first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Nicolet Bankshares held 1,500 shares of Novartis worth $235K as of Q2 2026.
Nicolet Bankshares left its Novartis share count unchanged in Q2 2026.
Novartis made up 0.01% of Nicolet Bankshares's portfolio in Q2 2026, its #562 holding.
Nicolet Bankshares first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Nicolet Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.